Accessibility: Skip TopNav
RS BioTherapeutics is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer
Michelle L. Shuffett, MD, Chief Medical Officer of RS BioTherapeutics
Format
JPEG
Quelle:
RS BioTherapeutics
Downloads
Originalgröße
Groß
Mittel
Klein